This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sakas, D. E. Articles by Zervas, N. T. Search for Related Content PubMed PubMed Citation Articles by Sakas, D. E. Articles by Zervas, N. T.

Stroke, Vol 25, 197-201, Copyright © 1994 by American Heart Association

ARTICLES

The perfluorocarbon fluoromethyloadamantane offers cerebral protection in a model of isovolemic hemodilution in rabbits

DE Sakas, RM Crowell, K Kim, K Korosue and NT Zervas
Neurosurgical Service, Massachusetts General Hospital, Boston 02114.

BACKGROUND AND PURPOSE--Perfluorocarbons (PFCs) are considered promising cerebral protection agents because they could combine the beneficial effects of decreased blood viscosity with enhanced oxygen- carrying capacity and oxygen tissue delivery, but trials of PFCs as hemodilutants have been very limited. We evaluated fluoromethyloadamantane (FMA), a new perfluorocarbon compound, as an isovolemic hemodilutant and compared it with low-molecular-weight dextran 40 (D40) and a control group. METHODS--Through a transorbital craniectomy, the internal carotid, anterior, and middle cerebral arteries were coagulated to create a cerebral infarction in anesthetized, mechanically ventilated rabbits. No other experimental procedure was performed in control animals. In the two other groups, hemodilution was commenced 30 minutes after the arterial occlusion with either D40 or FMA. Hemodynamic parameters and brain and systemic temperature were monitored throughout the experiments. All animals were killed 6 hours after the arterial occlusion. RESULTS--Hemodynamic and metabolic parameters and blood oxygen content were not affected by the infusion of either FMA or D40. Brain and systemic temperature remained constant. The ratio of infarct volume to the hemispheric volume was 19.6 +/- 3.7% in the FMA group (n = 17), 19.9 +/- 4.6% in the D40 group (n = 16), and 40.3 +/- 5.7% in the control group (n = 17). The difference in infarct volume of both FMA and D40 animals compared with controls was statistically significant (P < .01) when tested with Student's t test. There was no significant difference between FMA and D40 groups. CONCLUSIONS--These results suggest that FMA has cerebral protective properties and should be purified, optimized, and further tested experimentally to develop a stable, efficient, and safe oxygen carrier, potentially suitable for clinical trials.

This article has been cited by other articles:

				B. D. Spiess Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics J Appl Physiol, April 1, 2009; 106(4): 1444 - 1452. [Abstract] [Full Text] [PDF]

				A. T. Kawaguchi, D. Fukumoto, M. Haida, Y. Ogata, M. Yamano, and H. Tsukada Liposome-Encapsulated Hemoglobin Reduces the Size of Cerebral Infarction in the Rat: Evaluation With Photochemically Induced Thrombosis of the Middle Cerebral Artery Stroke, May 1, 2007; 38(5): 1626 - 1632. [Abstract] [Full Text] [PDF]